Our device is CE marked, sterile, class IV. The packaging has undergone validation under ISTA 3A-elongated. The device is packaged in an inner pouch, which is then placed in a box; several boxes are packaged in an outer shipping box for distribution.
We want to add a new supplier for the product box (the one in which the pouch is placed). The supplier is approved through our quality system and the box has the same specifications as the original box.
Would a new packaging validation be required, or can this be simply addressed with a risk analysis since the materials and dimensions of the box are the same?
I am unsure of whether this meets the definition of a "substantial change" under NB-MED/2.5.2/Rec2 as it's a change in a validated system, but not a "true" change since the new box should be identical to the old.
Thanks for any input!
We want to add a new supplier for the product box (the one in which the pouch is placed). The supplier is approved through our quality system and the box has the same specifications as the original box.
Would a new packaging validation be required, or can this be simply addressed with a risk analysis since the materials and dimensions of the box are the same?
I am unsure of whether this meets the definition of a "substantial change" under NB-MED/2.5.2/Rec2 as it's a change in a validated system, but not a "true" change since the new box should be identical to the old.
Thanks for any input!